🇺🇸 FDA

Intelligence · Clinical Pipeline

Phase III Pipeline Programs

Late-stage pivotal and registrational clinical programs nearing regulatory submission.

Programs
5,427

Quick answer

NovaPharmaNews tracks 5,427 phase iii pharmaceutical pipeline programs from ClinicalTrials.gov. Late-stage pivotal and registrational clinical programs nearing regulatory submission.

Top sponsors

Page 80 of 114

  1. Rifampicin

    United Therapeutics Europe Ltd

    Severe Acute Malnutrition

    phase 3 small molecule active

    1 trial

  2. Rifaximin

    Hospital Authority, Hong Kong

    Decompensated Cirrhosis

    phase 3 small molecule terminated

    1 trial

  3. Rifaximin

    The First People's Hospital of Lianyungang

    Crohn Disease

    phase 3 small molecule active

    1 trial

  4. Rilonacept

    Kiniksa Pharmaceuticals International, plc

    Recurrent Pericarditis

    phase 3 small molecule completed

    1 trial

  5. Rilonacept

    Regeneron UK Limited

    Gout

    phase 3 mab completed

    3 trials

  6. Rilonacept

    Regeneron UK Limited

    Acute Gout Flare

    phase 3 small molecule completed

    1 trial

  7. Rilonacept 80 mg

    Regeneron UK Limited

    Intercritical Gout

    phase 3 small molecule completed

    1 trial

  8. Rilotumumab

    Amgen

    Gastric Cancer

    phase 3 small molecule terminated

    1 trial

  9. Riluzole

    United Therapeutics Europe Ltd

    Spinal Cord Injury

    phase 3 small molecule terminated

    1 trial

  10. Rilvegostomig

    AstraZeneca

    Non-small Cell Lung Cancer

    phase 3 small molecule active

    1 trial

  11. Rilvegostomig, DS-8201a, MYCOPHENOLATE MOFETIL, PEMBROLIZUMAB, INFLIXIMAB, CARBOPLATIN, DOCETAXEL, PACLITAXEL

    AstraZeneca AB

    HER2-Expressing (IHC 3+/IHC 2+), Mismatch Repair Proficient (pMMR), Primary Advanced or Recurrent Endometrial Cancer

    phase 3 small molecule active

    1 trial

  12. Rilvegostomig, TEGAFUR, GLUCOSE, INFLIXIMAB, CAPECITABINE, CISPLATIN, MYCOPHENOLATE MOFETIL, TEGAFUR, CAPECITABINE, GEMCITABINE, SODIUM CHLORIDE

    AstraZeneca AB

    Adenocarcinoma of the biliary tract (intrahepatic or extrahepatic cholangiocarcinoma or muscle invasive gallbladder cancer GBC)

    phase 3 small molecule active

    1 trial

  13. Rilzabrutinib

    Sanofi-aventis Healthcare Pty Ltd

    immune thrombocytopenia (ITP)

    phase 3 small molecule active

    1 trial

  14. Rilzabrutinib

    Principia Biopharma, a Sanofi Company

    Immune Thrombocytopenia

    phase 3 small molecule active

    1 trial

  15. Rilzabrutinib, Composition of placebo is identical to that of IMP except that 400mg active ingredient is replaced with 400mg mannitol.

    Lacuna Pharma Pty Ltd

    Immune Thrombocytopenia (ITP)

    phase 3 small molecule active

    1 trial

  16. Rimegepant

    Pfizer

    Migraine

    phase 3 small molecule active

    1 trial

  17. Rimegepant Placebo, VYDURA 75 mg oral lyophilisate, 35 mg oral lyophilisate, 25 mg oral lyophilisate, 50 mg oral lyophilisate

    Pfizer Australia Pty Ltd

    Migraine (with or without aura)

    phase 3 small molecule active

    1 trial

  18. Rimonabant

    Sanofi Pasteur

    Obesity

    phase 3 small molecule terminated

    1 trial

  19. Rina-S

    Genmab A/S

    Ovarian Cancer

    phase 3 small molecule active

    1 trial

  20. Riociguat

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Chronic Thromboembolic Pulmonary Hypertension

    phase 3 small molecule active

    1 trial

  21. Risankizumab

    AbbVie

    Psoriasis

    phase 3 small molecule active

    1 trial

  22. Risankizumab

    AbbVie

    Palmoplantar Pustulosis (PPP)

    phase 3 small molecule completed

    1 trial

  23. Risankizumab, Placebo for Risankizumab Solution for injection in prefilled syringe, ABBV-066

    AbbVie Deutschland GmbH & Co. KG

    Psoriatic Arthritis

    phase 3 small molecule active

    1 trial

  24. Risankizumab, Risankizumab placebo solution for infusion, ABBV-066 / Risankizumab, ABBV-066, Risankizumab placebo solution for injection in pre-filled syringe, Risankizumab

    AbbVie Deutschland GmbH & Co. KG

    Ulcerative Colitis

    phase 3 small molecule active

    1 trial

  25. Ritlecitinib tosilate, Placebo to match ritlecitinib 50 mg, Ritlecitinib, Placebo to match ritlecitinib 30 mg

    Pfizer Australia Pty Ltd

    Alopecia areata

    phase 3 small molecule active

    1 trial

  26. Ritlecitinib tosilate, Ritlecitinib Tosilate

    Pfizer Australia Pty Ltd

    Alopecia areata

    phase 3 small molecule active

    1 trial

  27. Rituximab

    United Therapeutics Europe Ltd

    Follicular Lymphoma

    phase 3 small molecule completed

    1 trial

  28. Rituximab

    The First People's Hospital of Lianyungang

    Diffuse Large B-cell Lymphoma

    phase 3 small molecule active

    3 trials

  29. Rituximab

    Hospital Authority, Hong Kong

    Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis

    phase 3 mab completed

    1 trial

  30. Rituximab

    Janssen Cilag International NV

    Chronic Lymphocytic Leukemia

    phase 3 small molecule completed

    1 trial

  31. Rituximab

    The First People's Hospital of Lianyungang

    Refractory Myasthenia Gravis

    phase 3 small molecule active

    1 trial

  32. Rituximab

    United Therapeutics Europe Ltd

    Kidney Transplant Rejection

    phase 3 small molecule terminated

    1 trial

  33. Rituximab

    Lxo Ireland Designated Activity Company

    Lupus Nephritis

    phase 3 mab terminated

    1 trial

  34. Rituximab (RTX)

    Incyte

    Diffuse Large B-cell Lymphoma

    phase 3 small molecule completed

    1 trial

  35. Rituximab 375 mg/m^2

    Takeda

    Mantle Cell Lymphoma

    phase 3 small molecule completed

    1 trial

  36. Rivaroxaban

    Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

    Atrial Fibrillation

    phase 3 small molecule completed

    1 trial

  37. Rivaroxaban (Xarelto, BAY59-7939)

    Bayer HealthCare AG

    Venous Thromboembolism

    phase 3 small molecule completed

    2 trials

  38. Rivaroxaban (Xarelto, BAY59-7939)

    Bayer HealthCare AG

    Prevention & Control

    phase 3 small molecule completed

    1 trial

  39. Rivaroxaban (Xarelto, BAY59-7939)

    Bayer HealthCare AG

    Pulmonary Embolism

    phase 3 small molecule completed

    1 trial

  40. Rivaroxaban 2.5 Mg Oral Tablet

    The George Institute

    Chronic Kidney Diseases

    phase 3 small molecule completed

    1 trial

  41. Rivaroxaban 2.5 mg

    Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

    Acute Coronary Syndrome

    phase 3 small molecule completed

    1 trial

  42. Rivastigmine Transdermal System

    United Therapeutics Europe Ltd

    Parkinson Disease

    phase 3 small molecule completed

    1 trial

  43. RoActemra 20 mg/mL concentrate for solution for infusion, MabThera 500 mg concentrate for solution for infusion, Vincristine Sulfate 1 mg/ml solution for injection, Neulasta 6 mg solution for injection, AZD0486, RoActemra 20 mg/mL concentrate for solution for infusion, Truxima 500 mg concentrate for solution for infusion, Ribodoxo® 2 mg/ml Injektionslösung, Prednison 20 mg GALEN®, AZD0486, Endoxan 500 mg, poeder voor oplossing voor injectie, Ruxience 500 mg concentrate for solution for infusion

    AstraZeneca AB

    Large B-cell Lymphoma

    phase 3 small molecule active

    1 trial

  44. RoActemra 20 mg/mL concentrate for solution for infusion, Tofidence 20 mg/mL concentrate for solution for infusion, Avtozma 20 mg/mL concentrate for solution for infusion., SODIUM CHLORIDE, Tyenne 20 mg/ml concentrate for solution for infusion

    Pari Pharma GmbH

    Chondrocalcinosis

    phase 3 small molecule active

    1 trial

  45. Robotic Gastrectomy

    The First People's Hospital of Lianyungang

    Gastric Cancer (GC)

    phase 3 other active

    1 trial

  46. Rocatinlimab, Placebo for AMG 451

    Amgen

    Prurigo Nodularis

    phase 3 small molecule active

    1 trial

  47. Roflumilast

    AstraZeneca

    Asthma

    phase 3 small molecule completed

    1 trial

  48. Roflumilast

    AstraZeneca

    COPD

    phase 3 small molecule completed

    1 trial

Frequently asked questions

How many Phase III pipeline programs are in the directory?

5,427 published programs match this development stage in our ClinicalTrials.gov index.

What defines this pipeline stage?

Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.

Data attribution: Data sources · All pipeline programs

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.